Navigation Links
Hepatitis Awareness: Bringing Attention to a Silent Epidemic
Date:5/22/2013

ALEXANDRIA, Va., May 22, 2013 /PRNewswire/ -- Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans. More than 75 percent of those with hepatitis C are unaware they have the virus.

Hepatitis B and C Testing and Awareness Day in the U.S. House of Representatives will take place at 10:00 am - 2:00 pm in the Rayburn Foyer of the Rayburn House Office Building in Washington, D.C.

The American Association for the Study of Liver Diseases (AASLD) is pleased to participate with the Congressional Hepatitis Caucus, the National Viral Hepatitis Roundtable, the Community Education Group, Hepatitis B Initiative of Washington DC, Caring Ambassadors Program, the National Alliance of State and Territorial AIDS Directors, the Association of Chinese American Physicians, and private industry to provide testing for hepatitis B and C.  

In May 2011, the United States Department of Health and Human Services (HHS) released "Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis." The plan runs through 2013, and AASLD -- the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease -- welcomes the HHS announcement that it intends to update and renew the plan for 2014-2016.

Access to care and support of liver disease research are at the center of AASLD's advocacy efforts and Hepatitis Awareness Month and hepatitis testing events are necessary to make Americans aware that they can now be tested and treated for hepatitis C.

Research in the area of hepatitis C has led to FDA approval of two direct acting antiviral drugs for the treatment of hepatitis C, and numerous other direct acting antiviral drugs are in the development pipeline. AASLD looks forward to -- and its members work di
'/>"/>

SOURCE American Association for the Study of Liver Diseases
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
2. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
3. Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets, Says Frost & Sullivan
4. The race toward an interferon free world: The current field of Hepatitis C Virus treatment research, including recent financial deals
5. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
6. Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
7. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
8. Specialty drug costs account for more than 50 percent of the total cost of care for rheumatoid arthritis and hepatitis C patients
9. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
10. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
11. Computer Modeling Reveals How Surprisingly Potent Hepatitis C Drug Works
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3,  2015 ... human-made bio-artificial devices, which are implanted or ... natural organs. These include artificial heart, kidney, ... as polymers (polyurethane, polysulfone, and porous polypropylene), ... develop artificial organs. These organs are incorporated ...
(Date:9/3/2015)... Sept. 3, 2015 About dry eye syndrome ... due to deficient tear production or quick tear evaporation ... two types: aqueous tear deficient dry eye and evaporative ... glands do not produce enough tears, whereas meibomian gland ... lipids to slow tear evaporation and maintain tear stability. ...
(Date:9/3/2015)... 2015  Ascendis Pharma A/S (Nasdaq: ... that applies its innovative TransCon technology to ... plans to present at several upcoming investor ... in BostonDate: , Thursday, September 10, 2015 Time: ... Merrill Lynch Global Healthcare Conference in LondonDate: ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... , Ruling Opens Door to Physician Assisted ... Montana Supreme Court ruled that state law does not contain ... drugs to patients. This decision endangers the lives of the ... people,s lives, the law needs to draw a clear distinction ...
... For the twelfth consecutive year, Rev. Nicholas Hood, III, ... save lives during New Year,s Eve celebrations. Rev. Hood, ... Plan (HAP) and the Wayne County Sheriff,s Office, is asking ... without gunfire. The hope is that there will be ...
Cached Medicine Technology:Montana Supreme Court Decision Endangers Most Vulnerable Citizens 2Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Year's Eve Celebrations 2
(Date:9/4/2015)... CO (PRWEB) , ... September 04, 2015 , ... Mile ... the ways in which a lack of funding for sidewalks, bike paths, and other ... the report, while the Denver region spends billions of dollars to expand public transit, ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the surrounding communities, is launching a charity effort to provide for the family ... to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... three separate “Partner of the Year” awards at this year’s Microsoft Worldwide Partner ... Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform services, the ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy ... compete in the Ironman World Championships in Kona on October 10th. , Mike is ... Brain Injury (TBI) through combat and the cutting-edge treatments that restore their quality of ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... November 2008 -- In the December issue of ... Curtis Nickel and associates report on the evidence ... urinary tract symptoms (LUTS) in men enrolled in ... DUtasteride of prostate Cancer Events) trial is a ...
... options dwindle or are exhausted, terminally ill-patients often ... therapies. However, a team of researchers from Wake ... Medical Center and Unity Health System, report that ... governing end-of-life care may be leaving many medical ...
... to the Power of the Xevo TQ System,s Quantitative and Qualitative ... ... Nov. 13 Focused on the,process of helping firms to move ... showcase innovative,UltraPerformance LC(R) (UPLC) and mass spectrometry (MS) solutions at the,American ...
... Housing Industry Veteran Joins A Place for Mom, the Nation,s Largest Senior ... ... A Place for Mom, a nationwide senior care referral service for care ... veteran Rae Krivohlavek as a market development coach. Krivohlavek brings ...
... today announced that it has been named the Favorite,Healthcare ... 2008 People,s,Picks Awards. The awards, sponsored by NWJobs.com and ... from the general public for their,favorite Northwest employers. Northwest ... category., "We,re delighted to receive this award on ...
... Vaginal Symptom Associated,With Menopause, COLLEGEVILLE, Pa., Nov. ... has been approved by the U.S.,Food and Drug ... new less,frequent twice-weekly dosing regimen to treat moderate ... a division of Wyeth (NYSE: WYE )., ...
Cached Medicine News:Health News:Relationship between prostate information and lower urinary-tract symptoms evident 2Health News:Doctors' questions about end-of-life legalities may result in patient pain 2Health News:Doctors' questions about end-of-life legalities may result in patient pain 3Health News:Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008 2Health News:Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008 3Health News:A Place for Mom Hires Former VP of Sales and Marketing of Assisted Living Concepts as Market Development Coach 2Health News:Northwest Hospital & Medical Center Named Favorite Healthcare Company 2Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 2Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 3Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 4
Spherical Burr for FR030R, 5 mm....
Cutting Burr with dental shank, tungsten carbide, 0,7 mm, ISO-No. 007, packing unit 10 pieces....
Hough Hough Burr-Saw for Crurotomy, 1 mm, ISO-No. 010....
"Rosen" burr, 0,7 mm, ISO-No. 007....
Medicine Products: